Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion

被引:43
作者
Li, Maolan [1 ]
Shen, Jun [1 ]
Wu, Xiangsong [1 ]
Zhang, Bingtai [2 ]
Zhang, Rui [3 ]
Weng, Hao [1 ]
Ding, Qian [1 ]
Tan, Zhujun [1 ]
Gao, Guofeng [2 ]
Mu, Jiasheng [1 ]
Yang, Jiahua [1 ]
Shu, Yijun [1 ]
Bao, Runfa [1 ]
Ding, Qichen [1 ]
Wu, Wenguang [1 ]
Cao, Yang [1 ]
Liu, Yingbin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200092, Peoples R China
[2] Shanxi Med Univ, Hosp 2, Dept Gen Surg, Taiyuan, Peoples R China
[3] Inner Mongolia Med Univ, Affiliated Hosp, Dept Surg Oncol, Hohehot, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatoma-derived growth factor; Cell proliferation; Gallbladder cancer; RNA interference;
D O I
10.1007/s12032-013-0587-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatoma-derived growth factor (HDGF), a heparin-binding growth factor, has a wide range of biological functions, including mitogenic activity and vascular development. Recent studies demonstrated that HDGF also acted as an oncogene with aberrantly increased activity in multiple human cancers; however, little is known about the biological function of HDGF in gallbladder cancer (GBC). In this study, we focused on the clinical significance and biological functions of HDGF in GBC and found that Nuclear HDGF protein overexpression was frequently detected in GBC tissues. Patients with nuclear HDGF-positive tumors had worse overall survival than patients with HDGF-negative tumors. Furthermore, treatment of GBC lines with HDGF-targeting siRNA oligonucleotides (HDGF-siRNA) significantly reduced the proliferation of GBC-SD and SGC-996 cell lines and diminished both anchorage-independent growth on soft agar and cell migration. These data indicate that HDGF acts as a putative oncogene in GBC and could be a novel diagnostic and therapeutic target for GBC.
引用
收藏
页数:8
相关论文
共 20 条
[11]   Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation [J].
Mao, Jianshan ;
Xu, Zefeng ;
Fang, Yongming ;
Wang, Haijun ;
Xu, Jinghong ;
Ye, Jinjia ;
Zheng, Shu ;
Zhu, Yongliang .
CANCER SCIENCE, 2008, 99 (11) :2120-2127
[12]   shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer [J].
Meng, Jie ;
Xie, Wei ;
Cao, Liming ;
Hu, Chengping ;
Zhen, Zhiyuan .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2010, 42 (01) :52-57
[13]   Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas [J].
Pinheiro, Celine ;
Longatto-Filho, Adhemar ;
Scapulatempo, Cristovam ;
Ferreira, Luisa ;
Martins, Sandra ;
Pellerin, Luc ;
Rodrigues, Mesquita ;
Alves, Venancio A. F. ;
Schmitt, Fernando ;
Baltazar, Fatima .
VIRCHOWS ARCHIV, 2008, 452 (02) :139-146
[14]   Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer [J].
Ren, Hening ;
Chu, Zuoming ;
Mao, Li .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) :1106-1112
[15]   p53 Negatively Regulates the Hepatoma Growth Factor HDGF [J].
Sasaki, Yasushi ;
Negishi, Hideaki ;
Idogawa, Masashi ;
Yokota, Ikuko ;
Koyama, Ryota ;
Kusano, Masanobu ;
Suzuki, Hiromu ;
Fujita, Masahiro ;
Maruyama, Reo ;
Toyota, Minoru ;
Saito, Tsuyoshi ;
Tokino, Takashi .
CANCER RESEARCH, 2011, 71 (22) :7038-7047
[16]   Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer [J].
Uyama, Hirokazu ;
Tomita, Yasuhiko ;
Nakamura, Hideji ;
Nakamori, Shoji ;
Zhang, Binglin ;
Hoshida, Yoshihiko ;
Enomoto, Hirayuki ;
Okuda, Yorihide ;
Sakon, Masato ;
Aozasa, Katsuyuki ;
Kawase, Ichiro ;
Hayashi, Norio ;
Monden, Morito .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6043-6048
[17]   Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1 [J].
Wang, Jian-Wei ;
Peng, Shu-You ;
Li, Jiang-Tao ;
Wang, Yong ;
Zhang, Zhi-Ping ;
Cheng, Yan ;
Cheng, De-Qing ;
Weng, Wei-Hong ;
Wu, Xiang-Song ;
Fei, Xiao-Zhou ;
Quan, Zhi-Wei ;
Li, Ji-Yu ;
Li, Song-Gang ;
Liu, Ying-Bin .
CANCER LETTERS, 2009, 281 (01) :71-81
[18]   Gallbladder cancer: Lessons from a rare tumour [J].
Wistuba, II ;
Gazdar, AF .
NATURE REVIEWS CANCER, 2004, 4 (09) :695-706
[19]   Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma [J].
Yamamoto, Shinji ;
Tomita, Yasuhiko ;
Hoshida, Yoshihiko ;
Morii, Eiichi ;
Yasuda, Takushi ;
Doki, Yuichiro ;
Aozasa, Katsuyuki ;
Uyama, Hirokazu ;
Nakamura, Hideji ;
Monden, Morito .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (07) :2141-2149
[20]   Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer [J].
Zhou, Yanyan ;
Zhou, Nanxiang ;
Fang, Weiyi ;
Huo, Jirong .
DIAGNOSTIC PATHOLOGY, 2010, 5